Literature DB >> 11557272

Activated CD8(+) T cells from aged mice exhibit decreased activation-induced cell death.

H C Hsu1, J Shi, P Yang, X Xu, C Dodd, Y Matsuki, H G Zhang, J D Mountz.   

Abstract

To uncouple the defects of activation and apoptosis of T cells from aged mice, we used anti-CD3 plus IL-2 stimulation to induce an activation response and analyzed the subsequent activation-induced cell death (AICD) response of T cells from 16-month-old mice. The results herein demonstrate that T cells from 16-month-old mice could be activated by anti-CD3-induced activation signals but exhibited distinct phenotypic and functional features compared to young (2-month-old) mice. These include a decrease in AICD, a delayed entry into the cell cycle, and a decreased telomerase activity. The decreased AICD of T cells from 16-month-old mice is associated with a decreased expression of Fas and Fas ligand (FasL), decreased susceptibility to anti-Fas-induced apoptosis, and an increased expansion of a CD8(+) T-cell population. Prior to activation, these T cells exhibit a phenotype that is CD44(hi)CD62L(hi). After stimulation, these T cells produced high levels of the pro-inflammatory cytokine, IFN-gamma, and developed an increased population of IFN-gamma(+)IFN-gamma R(-) T cells. Our results suggest that there is a dysregulation in T-cell homeostasis in aged mice associated with a decrease in AICD of CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557272     DOI: 10.1016/s0047-6374(01)00279-2

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  9 in total

1.  Increased vitamin D is associated with decline of naïve, but accumulation of effector, CD8 T cells during early aging.

Authors:  Yong Gil Hwang; Hui-Chen Hsu; Fei-Chu Lim; Qi Wu; PingAr Yang; Gordon Fisher; Gary R Hunter; John D Mountz
Journal:  Adv Aging Res       Date:  2013-05

Review 2.  The immune system in the elderly: activation-induced and damage-induced apoptosis.

Authors:  Lia Ginaldi; Massimo De Martinis; Daniela Monti; Claudio Franceschi
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  B cells from aged mice exhibit reduced apoptosis upon B-cell antigen receptor stimulation and differential ability to up-regulate survival signals.

Authors:  C L Montes; B A Maletto; E V Acosta Rodriguez; A Gruppi; M C Pistoresi-Palencia
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

4.  Naive CD4 T cells from aged mice show enhanced death upon primary activation.

Authors:  Hamid Mattoo; Matthew Faulkner; Usha Kandpal; Rituparna Das; Virginia Lewis; Anna George; Satyajit Rath; Jeannine M Durdik; Vineeta Bal
Journal:  Int Immunol       Date:  2009-09-11       Impact factor: 4.823

Review 5.  Metabolic syndrome, hormones, and maintenance of T cells during aging.

Authors:  Hui-Chen Hsu; John D Mountz
Journal:  Curr Opin Immunol       Date:  2010-06-28       Impact factor: 7.486

6.  Intrinsic defects in CD8 T cells with aging contribute to impaired primary antiviral responses.

Authors:  Jiu Jiang; Erin M Fisher; Donna M Murasko
Journal:  Exp Gerontol       Date:  2013-03-06       Impact factor: 4.032

7.  Enhancement of cytotoxic T-lymphocyte response in aged mice by a novel treatment with recombinant AdIL-12 and wild-type adenovirus in rapid succession.

Authors:  Jian Chen; John Wang; Jun Li; Qi Wu; Fei Chu Lim; Pingar Yang; Hui-Chen Hsu; David T Curiel; John D Mountz
Journal:  Mol Ther       Date:  2008-06-10       Impact factor: 11.454

Review 8.  Immunosupportive therapies in aging.

Authors:  Tamas Fülöp; Anis Larbi; Katsuiku Hirokawa; Eugenio Mocchegiani; Bruno Lesourds; Stephen Castle; Anders Wikby; Claudio Franceschi; Graham Pawelec
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

9.  Persistent inflammation and T cell exhaustion in severe sepsis in the elderly.

Authors:  Shigeaki Inoue; Kodai Suzuki; Yukako Komori; Yukiko Morishita; Kyoko Suzuki-Utsunomiya; Katsuto Hozumi; Sadaki Inokuchi; Takehito Sato
Journal:  Crit Care       Date:  2014-06-24       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.